Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products ...

A new report has found more children than ever are not in school, with the number of lost days of learning up nearly 70% in five years. It is the most vulnerable children who skip school, are ...

Botox (onabotulinumtoxinA) is a brand-name injection prescribed to help prevent headaches in adults with chronic migraine. This article covers topics such as side effects, dosage, and how Botox works.

Pete Hegseth has lived in the public eye for years. As a well-known television personality and political commentator, he has drawn significant interest in his personal life. In late 2024, Donald ...

Being a parent in the digital age is a losing battle, according to Grimes. In a Thursday thread post shared on X, the social media platform owned by Musk, Grimes opened up about her unsuccessful ...

Beyoncé and Jay-Z are the proud parents to three children, who they have worked hard to give as normal lives as possible considering their global celebrity. The power couple rarely talk about ...

Rachel Rosen receives funding from Independent Social Research Foundation. She is affiliated with BDS @ UCL. Mai Abu Moghli is a policy member at Al- Shabaka: the Palestinian Policy Network.

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

A migraine cocktail is a term that’s used to describe a combination of medications that can help you find relief from a migraine attack. It’s estimated that 1 in 7 adults in the United States ...

The American College of Physicians (ACP) strongly recommends adding a triptan to a nonsteroidal anti-inflammatory drug (NSAID) to treat nonpregnant and nonlactating adults with moderate to severe ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 ...